Press release
Nonalcoholic Steatohepatitis (NASH) - Drug Pipeline Landscape, 2022 | Ascletis Pharma Inc, Astrazeneca Plc, Auransa Inc, Avaliv Therapeutics Inc
Nonalcoholic Steatohepatitis (NASH)
Nonalcoholic steatohepatitis (NASH) is a type of fatty liver disease. It is characterized by the accumulation of fat in the liver, inflammation, and damage. NASH can lead to cirrhosis, liver failure, and death. The exact cause of NASH is unknown, but it is believed to be associated with obesity, insulin resistance, and diabetes. Treatment of NASH is focused on weight loss, exercise, and the control of diabetes and insulin resistance.
NASH is most common in patients who are overweight or obese and other risk factors include diabetes, high cholesterol, high triglycerides, poor diet, metabolic syndrome, sleep apnea, underactive thyroid (hypothyroidism).
View Detailed Report Description : https://www.globalinsightservices.com/reports/non-alcoholic-steatohepatitis-nash-drug-pipeline-landscape-2022/
Report Highlights
Global Insight Service's, Nonalcoholic Steatohepatitis (NASH) - Drug Pipeline Landscape, 2022 report provides an overview of the Non-alcoholic steatohepatitis pipeline drugs. This report covers detailed insights on Nonalcoholic Steatohepatitis (NASH) drugs under development, assessment by target, mechanism of action, route of administration and molecule type. Product pipeline by companies, stage of development and key regulatory designations, deals and milestones have been presented to provide insights and thus help industry participants in their decision making. Nonalcoholic Steatohepatitis (NASH) pipeline report helps gain insights on drugs which are under development stage of drug development process across globally.
Methodology
The research process includes extensive secondary research on public domain and other authentic sources to add or update the pipeline products information. The secondary research sources include, but are not limited to company websites, annual reports, financial reports, company pipeline chart, investor presentations and SEC filings, journals and conferences, and clinical trials registries.
Request Sample Report : https://www.globalinsightservices.com/request-sample/GIS31004
Scope
The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. The report provides a review of pipeline therapeutics by companies based on information derived from company and industry-specific sources. The pipeline report covers assessment of therapeutics by mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. Comprehensive profiles of the pipeline products with details such as company overview, development stage; molecule type, target, mechanism of action, route of administration, dosage form, regulatory designations, key deals, clinical trials, and key upcoming milestones are included.
Get a 50% Off on Purchase of this Report Use Code (GIS2022SUP50) : https://www.globalinsightservices.com/checkout/single_user/GIS31004
Key Players
• 180 Life Corp
• 89bio, Inc.
• Acquist Theraputics Inc
• Akero Therapeutics, Inc
• Algernon Pharmaceuticals Inc
• Aligos Therapeutics
• Allysta Pharmaceuticals Inc
• Altay Therapeutics Inc
• Altimmune, Inc.
• Amgen
• Amytrx Therapeutics Inc
• AngioLab, Inc.
• AptaBio Therapeutics Inc
• AptamiR Therapeutics Inc
• Aria Pharmaceuticals Inc
• Arrowhead Pharmaceuticals
• Ascletis Pharma Inc
• Astrazeneca Plc
• Auransa Inc
• Avaliv Therapeutics Inc
• Axcella Health, Inc
• Bast Biotechnology LLC
• BenevolentAI Ltd
Request For Customization : https://www.globalinsightservices.com/request-customization/GIS31004
Reasons to buy Nonalcoholic Steatohepatitis (NASH) Report:
• Develop comprehensive understanding of market landscape - industry structure, value-chain, key players, trends, drivers, and challenges
• Drive revenue and market-entry strategy by gaining insights into which segments and geographies are largest and likely to grow fastest
• Formulate sales and marketing strategies by gaining understanding of competitors, their positioning, and strengths & weaknesses
• Develop business and M&A strategies through understanding of latest trends and emerging players in the market
• Refine your business plans by understanding impact of disruptions such as Covid-19 and Russia-Ukraine conflict on the market
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Nonalcoholic Steatohepatitis (NASH) - Drug Pipeline Landscape, 2022 | Ascletis Pharma Inc, Astrazeneca Plc, Auransa Inc, Avaliv Therapeutics Inc here
News-ID: 2857619 • Views: …
More Releases from Global Insight Services
Hydrogen Generation Market Poised to Grow from $155.5 Billion in 2024 to $410.6 …
The Hydrogen Generation Market is set to experience remarkable growth, expanding from $155.5 billion in 2024 to an estimated $410.6 billion by 2034, registering a robust CAGR of approximately 10.2%. Hydrogen generation involves producing and supplying hydrogen through various techniques, including steam methane reforming, electrolysis, and coal gasification. This market plays a pivotal role in supporting industries seeking cleaner energy solutions, spanning transportation, power generation, and industrial processes. As the…
Identity and Access Management Market Poised to Grow from $15.9 Billion in 2024 …
The Identity & Access Management (IAM) market is poised for substantial growth, expanding from an estimated $15.9 billion in 2024 to $38.2 billion by 2034 at a robust CAGR of approximately 9.2%. IAM encompasses systems, tools, and policies that manage digital identities and regulate user access within organizations. This includes solutions such as authentication, single sign-on, identity governance, and privileged access management. These technologies are essential for ensuring security, compliance,…
Endoscopy Devices Market Is Anticipated To Expand From $14.5 Billion In 2024 To …
Market Overview
The Endoscopy Devices Market is playing an increasingly important role in modern healthcare by supporting minimally invasive diagnostic and surgical procedures. These devices, which include endoscopes, visualization systems, and complementary instruments, allow physicians to examine internal organs with precision, leading to faster diagnoses, less trauma for patients, and improved recovery times. As the global burden of chronic diseases rises, the demand for such technologies continues to expand. Additionally, advancements…
Sustainable Fashion Market Is Anticipated To Expand From $13.8 Billion In 2024 T …
Market Overview
The Sustainable Fashion Market has gained remarkable momentum in recent years as consumers, brands, and policymakers increasingly recognize the need for eco-friendly and socially responsible alternatives in the fashion industry. Unlike conventional fashion, which is often criticized for its high carbon footprint and exploitative labor practices, sustainable fashion emphasizes the use of organic, recycled, and biodegradable materials, along with ethical supply chains and fair trade principles. This shift represents…
More Releases for NASH
The Growing Demand For NASH Treatment Amid Obesity Epidemic: A Key Catalyst Acce …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Non-Alcoholic Steatohepatitis (NASH) Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for non-alcoholic steatohepatitis (NASH) has seen a considerable expansion in the past few years. Its value is expected to rise from $4.5 billion in 2024 to $6.06 billion in 2025, marking…
Nonalcoholic Steatohepatitis (NASH) Market Massive Growth opportunity Ahead
Introduction
Nonalcoholic Steatohepatitis (NASH) is an advanced form of nonalcoholic fatty liver disease (NAFLD) characterized by fat accumulation in the liver along with inflammation and liver cell damage. If left untreated, NASH can progress to fibrosis, cirrhosis, liver failure, or hepatocellular carcinoma. Closely tied to the global obesity and diabetes epidemic, NASH has become a major healthcare burden, with millions affected worldwide and no widely approved curative therapy to date.
The NASH…
Non Alcoholic Steatohepatitis (NASH) Market Size to Hit $21,879 Million by 2028 …
According to our experience research team, Non Alcoholic Steatohepatitis (NASH) Market was valued at USD 1,569 Million in 2021, and the global Non Alcoholic Steatohepatitis (NASH) industry is projected to reach a value of USD 21,879 Million by 2028, at a CAGR of 60.4% during the forecast period 2022-2028
The report is focused on gaining various Non Alcoholic Steatohepatitis (NASH) market trends, dynamics, growth drivers, opportunities, weaknesses, strengths, and threats restraining…
NASH Market Insight and Landscape report
Report Snapshot:
NASH is one of the furthermost causes of liver disease worldwide and will probably emerge as the leading cause of end-stage liver disease in the coming years, with the disease affecting both adults and children. The epidemiology and demographic characteristics of NASH vary across different country level. Furthermore, individuals with NAFLD have a high frequency of metabolic comorbidities and could place a growing strain on health-care systems from their…
Nash releases debut EP 'She Don't Know'
London-based singer/songwriter Nash has released his debut EP She Don’t Know. Recorded at the legendary RAK Studios, She Don’t Know has the feel of 60s rock but with a modern twist, leaving the listener hooked throughout and wanting to come back for another listen. She Don’t Know’s leading single CK is an infectious number which is sure to be a hit for 2017.
Listening to the Beatles and Jack White growing…
Nash Technologies at GITEX/GULFCOMMS 2010
Harvey Nash subsidiary presents expert services to telecom operators in the Middle East, Africa and South Asia region
Nürnberg/Germany, 10th September 2010 – For the first time Nash Technologies will be present at GITEX/GULFCOMMS, the largest international trade event for mobile, fixed, IP and satellite communications for the Middle East, Africa and South Asia region, in Dubai from 17th to 21st October 2010 offering its telecom expert services. Nash Technologies will…
